Use of sensor-augmented insulin pump in patient with diabetes and cystic fibrosis: evidence for improvement in metabolic control.
Cystic fibrosis-related diabetes (CFRD) is a frequent complication of cystic fibrosis. We report the significant improvement of diabetes control and quality of life in a CFRD patient using the sensor-augmented insulin pump. The system gives the patient the highest degree of flexibility, which is required in CFRD since food intake and activity levels vary widely from day to day, depending on the rapid changes of health status.
Klupa
Tomasz
T
Department of Metabolic Diseases, Medical College, Jagiellonian University, Krakow, Poland. tomasz_klupa@yahoo.com
Małecki
Maciej
M
Katra
Barbara
B
Cyganek
Katarzyna
K
Skupień
Jan
J
Kostyk
Ewa
E
Pietrzyk
Jacek
J
Sieradzki
Jacek
J
D000328:Adult; D003550:Cystic Fibrosis / Q000097:blood / Q000150:complications*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control; D007003:Hypoglycemia / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D015918:Infusion Pumps, Implantable; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems
D007004:Hypoglycemic Agents; D007328:Insulin